Deferasirox
Links shared publicly online about this topic
Exjade (deferasirox) - Early Communication
fda.gov — “Early Communication describing an increased number of adverse events and deaths in patients using Exjade who are over sixty years old who have myelodysplastic syndrome (MDS).” View full resource at fda.gov
Most Recently Shared on September 25, 2009 at 7:51 pm By:
FDA “early communication†warning re deferasirox for MDS patients over age 60 http://j.mp/1X7rfr
FDA Alert: Exjade (deferasirox) - Early Communication
drugs.com — “FDA Alert: Exjade (deferasirox) - Early Communication” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 4:49 am By:
FDA Alert - FDA Reviewing Exjade (deferasirox) Safety Concerns - http://bit.ly/iMWrL
FDA Alert: Exjade (deferasirox): Boxed Warning
drugs.com — “FDA Alert: Exjade (deferasirox): Boxed Warning” View full resource at drugs.com
Most Recently Shared on February 19, 2010 at 12:00 am By:
FDA Alert - FDA Adds Boxed Warning for Exjade (deferasirox) - http://bit.ly/b8gQMo
How Does Deferasirox Reduce Liver Fibrosis? |
agajournals.wordpress.com — “How Does Deferasirox Reduce Liver Fibrosis? |” View full resource at agajournals.wordpress.com
Most Recently Shared on October 11, 2011 at 3:14 pm By:
New post from The AGA Journals Blog: How Does Deferasirox Reduce Liver Fibrosis? http://t.co/C6TkIAkb
Pediatrics Medical News about Chelating Agents Deferasirox
mdlinx.com — “Deferasirox: Oral, once daily iron chelator - an expert opinion” View full resource at mdlinx.com
Most Recently Shared on April 9, 2010 at 2:45 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Deferasirox: Oral, once daily iron chelator - an expert opinion: The Indian Journal of Pediatrics http://bit.ly/9MMkjR #peds
ingentaconnect Deferasirox/deferoxamine: Various toxicities (first report for sl...
ingentaconnect.com — “ingentaconnect Deferasirox/deferoxamine: Various toxicities (first report for sl...” View full resource at ingentaconnect.com
Most Recently Shared on June 28, 2011 at 3:22 am By:
Deferasirox/deferoxamine: Various toxicities (first report for sleep disorder with deferoxamine): 2 case reports... http://bit.ly/iiTeDQ
Boxed warning added to deferasirox label | HemOncToday
hemonctoday.com — “The FDA and Novartis Oncology today announced <A HREF="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/” View full resource at hemonctoday.com
Most Recently Shared on February 18, 2010 at 8:12 pm By:
HemOnc Today Oncology and Health News
#FDA Boxed warning added to deferasirox (Exjade) label http://ow.ly/18Oip
Deferasirox (ExjadeR) Treatment Provides Sustained Benefit In Beta-Thalassemia And Myocardial Siderosis
medicalnewstoday.com — “BARCELONA - Continued therapy with deferasirox (30-40 mg/kg/day) over two years is effective in removing cardiac iron in beta-thalassemia patients with mild-to-moderate and severe cardiac siderosi” View full resource at medicalnewstoday.com
Most Recently Shared on July 7, 2010 at 12:04 am By:
Deferasirox (ExjadeR) Treatment Provides Sustained Benefit In Beta-Thalassemia And Myocardial Siderosis http://mnt.to/3FNd #healthnews
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up
bloodjournal.hematologylibrary.org — “Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on May 31, 2011 at 3:29 pm By:
Sandra Cottingham Parenting Supporter and Health Business
Iron chelation with deferasirox in adult and pediatric patients ... http://bit.ly/mfNwDf
Deferasirox reduced iron burden in adults, children with thalassemia major | HemOncToday
hemonctoday.com — “Long-term iron chelation therapy with deferasirox appeared to effectively reduce iron burden in patients assigned to the drug for at least 4” View full resource at hemonctoday.com
Most Recently Shared on August 2, 2011 at 1:39 pm By:
HemOnc Today Oncology and Health News
Deferasirox reduced iron burden in adults, children with thalassemia major http://bit.ly/qzPXl2
News - Deferasirox Improves Iron Overload-Induced Liver Damage for Some Patients With Beta-Thalassaemia: Presented at ASH
docguide.com — “Deferasirox Improves Iron Overload-Induced Liver Damage for Some Patients With Beta-Thalassaemia: Pr” View full resource at docguide.com
Most Recently Shared on December 11, 2010 at 3:36 am By:
Sandra Cottingham Parenting Supporter and Health Business
Deferasirox Improves Iron Overload-Induced Liver Damage for Some ... http://bit.ly/eT4bws
Deferasirox for managing transfusional iron overlo... [Cochrane Database Syst Rev. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 7, 2010 at 10:43 am By:
Deferasirox for managing transfusional iron overload in people with sickle cell disease.: CONCLUSIONS: Deferasirox... http://bit.ly/9pvBVS
Preview Page - http://www.medscape.com/viewarticle/709579?src=smo_onc
cli.gs — “Preview Page - http://www.medscape.com/viewarticle/709579?src=smo_onc” View full resource at cli.gs
Most Recently Shared on September 29, 2009 at 12:52 am By:
Medscape Oncology Oncology and Health Site
#Hematology FDA Issues Early Communication Regarding Deferasirox Safety in MDS http://cli.gs/Aq459
Emergency Med Medical News about Kidney
mdlinx.com — “Acute renal failure and Fanconi syndrome due to deferasirox” View full resource at mdlinx.com
Most Recently Shared on April 30, 2010 at 10:31 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Acute renal failure and Fanconi syndrome due to deferasirox: Nephrology Dialysis Transplantation http://bit.ly/bsjnyZ #ER #mdlinx
Infectious Disease Article | Mucorales
mdlinx.com — “Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron” View full resource at mdlinx.com
Most Recently Shared on January 11, 2011 at 11:33 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron: Antimicrobial Agents and Che... http://bit.ly/flBwu8 #ID
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Serena Stockwell
Oncology Times: News, Analysis, Commentary, Controversy for Cancer Specialists; The Independent Hem/Onc News Source
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
